Muutke küpsiste eelistusi

Transplantation of the Pancreas Second Edition 2023 [Kõva köide]

  • Formaat: Hardback, 1304 pages, kõrgus x laius: 279x210 mm, kaal: 4383 g, 370 Illustrations, color; 138 Illustrations, black and white; XX, 1304 p. 508 illus., 370 illus. in color. In 2 volumes, not available separately., 2 hardbacks
  • Ilmumisaeg: 22-Sep-2023
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3031209982
  • ISBN-13: 9783031209987
Teised raamatud teemal:
  • Kõva köide
  • Hind: 234,00 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Tavahind: 275,29 €
  • Säästad 15%
  • Raamatu kohalejõudmiseks kirjastusest kulub orienteeruvalt 2-4 nädalat
  • Kogus:
  • Lisa ostukorvi
  • Tasuta tarne
  • Tellimisaeg 2-4 nädalat
  • Lisa soovinimekirja
  • Formaat: Hardback, 1304 pages, kõrgus x laius: 279x210 mm, kaal: 4383 g, 370 Illustrations, color; 138 Illustrations, black and white; XX, 1304 p. 508 illus., 370 illus. in color. In 2 volumes, not available separately., 2 hardbacks
  • Ilmumisaeg: 22-Sep-2023
  • Kirjastus: Springer International Publishing AG
  • ISBN-10: 3031209982
  • ISBN-13: 9783031209987
Teised raamatud teemal:

As the 1st edition was, the 2nd edition will also be the definitive text on Pancreas Transplantation.  

 

As stated in a review of the 1st edition in the New England Journal of Medicine (353;14:2005) this text “is…a complete reference text in the field of pancreatic transplantation [ with]….excellent chapters…[ and] excellent color illustrations of operative techniques.”  

This second edition is dedicated to David E.R. Sutherland, considered the “father” of pancreas transplantation. This textbook is the primary reference on pancreas transplantation for transplant surgeons (established and in-training), pancreas and HPB surgeons, diabetologists, endocrinologists, gastroenterologists, pancreatologists and other health professionals with a focus on transplantation and diabetes (cardiologists, neurologists, urologists, ophthalmologists). 

The 2nd edition is enlarged, updated and improved. It consists of 11 sections and a total of 50 chapters (of which 16 chapters have subchapters). The chapter authors are all considered international leaders in their fields and represent institutions from 4 continents (America: USA, Argentina, Brazil, Canada; Europe: Belgium, France, Germany, Italy, Norway, Spain, Switzerland, The Netherlands, UK ; Asia: China, Japan, South Korea, Russian Federation; Australia).

  

Compared to the 1st edition, the 2nd edition is organized in sections according to specific topics. The number of chapters has doubled. The number of national and international contributors has also almost doubled. Since the publication of the 1st edition in 2004, substantial progress has been made in Pancreas Transplantation specifically in regards to standardization of operative techniques and immunosuppression; significant improvements in patient and graft survival rates; and improved diagnosis and therapy of graft rejection and recurrence of disease. Pancreas transplants are no longer primarily performed in the USA and Europe for Type 1 Diabetes Mellitus: over the past 15 years, they have been performed with increasing frequency worldwide and also for Type 2 Diabetes Mellitus.  

 

The 2nd edition of this text covers all aspects of pancreas transplantation: Indication, recipient categories, surgical donor and recipient techniques, living donor transplantation, postoperative management and follow-up, post-transplant complications and malignancies, immunosuppression, treatment and diagnosis of rejection, impact on endocrine function and secondary complications of diabetes, recurrence of disease, quality of life, economic issues and overall outcome results. In addition, state-of-the art chapters focus on the classification, epidemiology and pathogenesis of type 1 and 2 diabetes mellitus as well as on other beta-cell replacement therapies including islet auto- and allo-transplantation.


Diabetes Mellitus: Classification and Diagnosis.- Epidemiology and
Pathogenesis of Diabetes Mellitus Type 1.- Epidemiology and Pathogenesis of
Diabetes Mellitus Type 2.- Nontransplant Treatment Options for Diabetes
Mellitus and Limitations.- History of Pancreas Transplantation.- Experimental
Pancreas Transplantation.- Organ Allocation.- Donor Selection.- Pancreas
Preservation.- Donor Procurement.- Surgical back-table procedures.- Recipient
selection and recipient categories.- Pretransplant Evaluation and Cardiac
Risk Assessment.- Recipient procedures.- Initial/Transplant hospitalization.-
Imaging Studies.- Surgical Complications.- Graft Thrombosis.- Medical
Complications.- Posttransplant Infections and PTLD.- Non-immunological
Endocrine Graft Dysfunction.- Immunosuppressive therapy.- Donor Specific
Antibodies and Antibody Mediated Rejection.- Immunobiology, Diagnosis, and
Treatment of Rejection.- Pancreas Graft Pathology.- Immunology.- Endocrine
Function and Metabolic Outcome (Dyslipidemia) including a comparison of
Pancreas vs. Islet Transplantation.- Impact on Secondary Complications of
Diabetes Mellitus.- Defining Outcomes for b-Cell Replacement Therapy.- The
Current State of Pancreas Transplantation in the World - A Registry Report.-
Outcome Comparison of Pancreas vs. Islet Transplantation.- Donation after
Cardiac Death.- Management of Graft Failure and Retransplantation.-
Transplantation of Minorities, Young and Elderly.- Long-Term Pancreas Graft
Function.- Quality of Life.- Pregnancy after Pancreas Transplantation.-
Formulas for successful Pancreas Transplant Programs.- Accreditation and
Certification.- Economic Issues including Insurance Coverage .- The Future of
Pancreas Transplantation.- Pancreas Autotransplantation.- Islet
Autotransplantation.- Islet Allotransplantation.- Islet Xenotransplantation.
Rainer W. G. Gruessner, MD, FACS, Department of Surgery, SUNY Downstate Health Sciences University, Brooklyn, New York, USA





Angelika C. Gruessner, MS, PhD, Department of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York, USA









Drs. Rainer and Angelika Gruessner are the recipients of the Richard C. Lillehei Award, which was bestowed on them at the 17th World Congress of the International Pancreas and Islet Transplant Association (IPITA) in Lyon, France, in 2019. According to IPITA, this biennial award is given since 2011 to an outstanding clinician and/or scientist for their substantial contributions towards advancing the field of pancreas transplantation. The 2019 Lillehei Award ceremony was one of the few occasions where husband and wife were awarded for their equal scientific contributions. Dr. Angelika Gruessner serves as the Scientific Director of the International Pancreas Transplant Registry (IPTR). Dr. Rainer Gruessner has served as Chairman of the Departments of Surgery at the University of Zurich, University of Arizona, and SUNY Downstate Health Sciences University and has directed pancreas transplant programs and performed pancreas transplants for more than 30 years.